Fundraising FoxHAWKTAIL — 2021 Investments
6 investments dated 2021 · listed companies and verified rows first · show all
Envisagenics uses AI-driven analysis of RNA splicing to discover novel drug targets for immuno-oncology and neurodegenerative diseases.
AI & Machine LearningBiotechMedical DevicesNew York, US
Martin Akerman, PhD(CEO & Co-founder)Martin Akerman(Founder)inMaria Luisa Pineda(Founder)in
Co-investorsDolby Family VenturesDynamk CapitalM12 (Microsoft's Venture Fund)Madrona Venture GroupRed Cell IncubationThird Kind Venture Capital
Software platform to improve drug discovery
AI & Machine LearningBiotechDeep TechNew York, US
David William Rooklin(Executive Officer, Director)Haotian Li(Director)
Co-investorsCollaborative FundNotation CapitalNYU Innovation Venture FundAcequia Capital (AceCap)Preface VenturesRefactor Capital+2 more
.png)
Teiko provides CLIA-validated high-dimensional cytometry services—including spectral flow and mass cytometry panels, blood preservation kits, gating, and a data analysis dashboard—for immune cell profiling in clinical trials.
BiotechDigital HealthHealthtechSalt Lake City, US
Ramji Srinivasan(Executive Officer, Director)inMatt(Co-founder)inMatthew Spitzer(Director)
BoardVictor Wang(Director)in
Co-investorsAlix VenturesCivilization Ventures Management, LlcHOF CapitalTau VenturesTwine VenturesWestern Technology Investment+2 more
Venice, US
Paul Eremenko(Founder)Jason Chua(Founder)Jon Gordon(Founder)
Co-investorsFourth RealmTrucks VCAirbus VenturesAndreessen HorowitzCoatue ManagementGlobal Founders Capital+7 more
XMTP is an open source, decentralized messaging protocol that uses quantum-resistant encryption to let developers build secure, programmable chat apps, mini-apps, and AI agents with native support for payments and digital assets.
Crypto & Web3CybersecurityDeveloper ToolsSocialWilmington, US
Matthew P. Galligan(Executive Officer, Director, Promoter)Shane McSimov(Executive Officer, Director, Promoter)Shane Mac(Founder)inMatt Galligan(Founder)
Co-investorsa16z cryptoAmbush CapitalAndreessen HorowitzBetaworksCoinbase VenturesFaction+16 more
Zafrens develops a unified drug discovery platform that integrates isolation, imaging, and sequencing workflows to accelerate the identification of therapeutic compounds across modalities.
AI & Machine LearningBiotechDeep TechSan Diego, US
Martin SmrcinainMaina NdunguinSwamy Vijayan(Executive Officer, Director)inYi ZhanginVikas Goelin
BoardJustin Briggsin
Co-investorsAcequia Capital (AceCap)Alix VenturesBlueYard CapitalFoundersX VenturesGlobal BrainIaso Ventures+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.